Rigel Pharmaceuticals Inc
RIGL
Revenue
57.60M
▲2.29M▲4.14%
3 Months ChangeAssets
163.98M
▲24.56M▲17.61%
3 Months ChangeLiabilities
160.69M
▲6.63M▲4.31%
3 Months ChangeFree Cash Flow
-25.86M
▼-5.84M▼-29.14%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-19
Form 8-K
ID: 0001104659-24-101327
2024-09-03
Form 8-K
ID: 0001104659-24-096047
2024-08-06
Form 8-K
ID: 0001104659-24-086271
2024-08-06
Form 10-Q
ID: 0001558370-24-011079
2024-06-27
Form 8-K
ID: 0001104659-24-075697
2024-06-25
Form 8-K
ID: 0001104659-24-074574
2024-05-29
Form 8-K
ID: 0001104659-24-066058
2024-05-07
Form 8-K
ID: 0001104659-24-058017
2024-05-07
Form 10-Q
ID: 0001558370-24-007041
2024-04-12
Form 8-K
ID: 0001104659-24-046527